Login / Signup

Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial.

Saeede SaadatiAmir SadeghiAsieh MansourZahra YariHossein PoustchiMehdi HedayatiBehzad HatamiAzita Hekmatdoost
Published in: BMC gastroenterology (2019)
IRCT20100524004010N24, this trial was retrospectively registered on May 14, 2018.
Keyphrases
  • phase ii
  • placebo controlled
  • clinical trial
  • phase iii
  • double blind
  • study protocol
  • oxidative stress
  • open label
  • randomized controlled trial
  • liver fibrosis
  • phase ii study
  • rectal cancer